These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31590184)

  • 1. Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board.
    Spellberg B; Nielsen TB; Gilbert DN; Shorr AF; Brass EP
    Ann Intern Med; 2019 Oct; 171(8):580-582. PubMed ID: 31590184
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic development - economic, regulatory and societal challenges.
    Årdal C; Balasegaram M; Laxminarayan R; McAdams D; Outterson K; Rex JH; Sumpradit N
    Nat Rev Microbiol; 2020 May; 18(5):267-274. PubMed ID: 31745330
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial drug discovery: lessons of history and future strategies.
    Travis A; Chernova O; Chernov V; Aminov R
    Expert Opin Drug Discov; 2018 Nov; 13(11):983-985. PubMed ID: 30136874
    [No Abstract]   [Full Text] [Related]  

  • 4. Priority pathogens and the antibiotic pipeline: an update.
    Beyer P; Paulin S
    Bull World Health Organ; 2020 Mar; 98(3):151. PubMed ID: 32132745
    [No Abstract]   [Full Text] [Related]  

  • 5. Together towards a common goal: REVIVE, a community of antimicrobial researchers brought together by the Global Antibiotic Research & Development Partnership (GARDP).
    Pentz-Murr A; Piddock LJV
    J Antimicrob Chemother; 2019 Jul; 74(7):1769-1770. PubMed ID: 30793751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steps to address anti-microbial drug resistance in today's drug discovery.
    Parish T
    Expert Opin Drug Discov; 2019 Feb; 14(2):91-94. PubMed ID: 30466326
    [No Abstract]   [Full Text] [Related]  

  • 7. Policy: An intergovernmental panel on antimicrobial resistance.
    Woolhouse M; Farrar J
    Nature; 2014 May; 509(7502):555-7. PubMed ID: 24877180
    [No Abstract]   [Full Text] [Related]  

  • 8. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
    Takebe T; Imai R; Ono S
    Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Europe to boost development of new antimicrobial drugs.
    Kirby T
    Lancet; 2012 Jun; 379(9833):2229-30. PubMed ID: 22715506
    [No Abstract]   [Full Text] [Related]  

  • 10. Call for the creation of an international panel on antimicrobial resistance.
    Vet Rec; 2014 May; 174(22):541. PubMed ID: 24920704
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic Pipeline Coordinators.
    Baraldi E; Lindahl O; Savic M; Findlay D; Årdal C
    J Law Med Ethics; 2018 Jun; 46(1_suppl):25-31. PubMed ID: 30146958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug development: Time for teamwork.
    May M
    Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427
    [No Abstract]   [Full Text] [Related]  

  • 13. A three-step plan for antibiotics.
    Nature; 2014 May; 509(7502):533. PubMed ID: 24877183
    [No Abstract]   [Full Text] [Related]  

  • 14. (Inter)nationalising the antibiotic research and development pipeline.
    Singer AC; Kirchhelle C; Roberts AP
    Lancet Infect Dis; 2020 Feb; 20(2):e54-e62. PubMed ID: 31753765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach.
    Noel GJ; Nambiar S; Bradley J;
    J Pediatric Infect Dis Soc; 2019 Mar; 8(1):60-62. PubMed ID: 29438520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New antibiotics for the clinical setting, an overview].
    Meylan S; Portillo Tunon V; Guery B
    Rev Med Suisse; 2020 Apr; 16(690):713-718. PubMed ID: 32301304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of machine learning techniques to innovative antibacterial discovery and development.
    Serafim MSM; Kronenberger T; Oliveira PR; Poso A; Honório KM; Mota BEF; Maltarollo VG
    Expert Opin Drug Discov; 2020 Oct; 15(10):1165-1180. PubMed ID: 32552005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-loop discovery platform integration is needed for artificial intelligence to make an impact in drug discovery.
    Saikin SK; Kreisbeck C; Sheberla D; Becker JS; A AG
    Expert Opin Drug Discov; 2019 Jan; 14(1):1-4. PubMed ID: 30488727
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic Resistance: The Need For a Global Strategy.
    Elder DP; Kuentz M; Holm R
    J Pharm Sci; 2016 Aug; 105(8):2278-87. PubMed ID: 27397433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the economic barriers of antibiotic R&D and how can we overcome them?
    Renwick M; Mossialos E
    Expert Opin Drug Discov; 2018 Oct; 13(10):889-892. PubMed ID: 30175625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.